According to FutureWise analysis the Aneurysm Treatment Market in 2025 is 5.72 billion, and is expected to reach US$ 10.6 billion by 2033 at a CAGR of 8.02%. Growth in the industry is largely driven by the rising cases of cerebrovascular and peripheral aneurysms, advancements in minimally invasive techniques, and the availability of flow-diverting stents and endovascular coils. Furthermore, novel biologic therapies and image-guided robotics are set to enhance procedural accuracy and reduce postoperative complications.

An aneurysm is an abnormal outpouching in the wall of an artery, typically resulting from a weakened area. If left untreated, an aneurysm has the potential to rupture, leading to serious complications such as internal bleeding, the formation of blood clots, and obstruction of blood flow within the artery. The consequences of a rupture or clot can be life-threatening, depending on the location of the aneurysm.

Aneurysms often do not produce any noticeable symptoms and may go undetected until a rupture occurs, which can result in critical medical emergencies. Diagnostic procedures to identify an aneurysm commonly include imaging techniques such as CT scans, CT or MRI angiography, and ultrasound.

Aneurysms are classified based on their size and structural characteristics, including fusiform, saccular, mycotic, and pseudoaneurysms. Management and treatment strategies are focused on preventing rupture. Depending on various factors such as the type, location, and size of the aneurysm, treatment options may include medication to enhance blood flow, manage cholesterol levels, and reduce blood pressure.

For large aneurysms at risk of rupture, surgical intervention may be required. This could involve procedures such as endovascular aneurysm repair (EVAR), open surgical approaches, endovascular coiling for cerebral aneurysms, microvascular clipping for cerebral aneurysms, or catheter embolization. Early detection and appropriate management are critical for the effective treatment of aneurysms.

Magnetically Guided Endothelial BioBots: Researchers have created biodegradable hydrogel carriers that contain magnetic nanoparticles and are coated with primed endothelial progenitor cells. These BioBots can be delivered through microcatheters and guided by external electromagnetic fields to adapt to the shapes of aneurysms. This approach promotes rapid endothelialization and reduces the risk of rupture.

FutureWise Market Research has published a report that provides an insightful analysis of Aneurysm Treatment Market trends that are affecting the overall market growth.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=179&type=requestsample

Aneurysm Treatment Market Segmentation:

By Product Type

  • Surgical Clipping
  • Endovascular Coiling
  • Flow diverters

By End User

  • Hospitals
  • Neurological Centres

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Competitive Landscape in Aneurysm Treatment Market:

  • Penumbra
  • Terumo Medical Incorporated
  • Medtronic Plc
  • Phenox GmbH B. Braun Melsungen AG
  • Stryker
  • Raumedic AG
  • DePuy Synthes
  • Integra Life Sciences Corporation
  • Orsan Medical Technologies
  • Spiegelberg GmbH
  • MicroPort Scientific Corporation
  • Codman
  • Shurtleff, Inc.

Recent developments by key players in Aneurysm Treatment Market:

Penumbra

In February 2025, Penumbra introduced the ACCESS25™ delivery microcatheter, a single-lumen device designed to enhance access to the neurovasculature for delivering Penumbra’s 0.020-inch coil platform. Compatible with Midway intermediate and Benchmark/BMX guide catheters, this device aims to improve trackability and stability during neurovascular embolization procedures

Terumo

In September 2025, Terumo Neuro launched the Aneurysm Treatment Alliance in the Europe, Middle East, and Africa (EMEA) region. This initiative aims to enhance physician collaboration and improve aneurysm care by granting access to Terumo's comprehensive portfolio of neurovascular products. The alliance focuses on advancing patient outcomes through innovative treatments and educational programs for healthcare professionals.

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=12307&license=multi

**Objectives of this Study: **

  1. To provide a comprehensive analysis of the Aneurysm Treatment Market By Product Type, By End User and By Region.
  2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
  3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
  4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
  • The customization services offered are free of charge with the purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com